XML 28 R77.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information (Financial Information For Each Reportable Segment) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2013
segment
Sep. 30, 2012
Sep. 30, 2011
Segment Reporting Information [Line Items]                      
Number of reportable segments                 3    
Revenues $ 39,857 $ 36,580 $ 37,082 $ 36,681 $ 37,432 $ 39,205 $ 39,094 $ 36,669 $ 150,200 $ 152,400 $ 120,458
Operating income (loss) 7,015 [1] (16,776) [1] 7,154 [1] 6,727 [1] 1,219 [1] 9,249 [1] 10,149 [1] 7,553 [1] 4,120 [1],[2] 28,170 [1] 34,883
Depreciation and amortization                 14,924 [3] 11,631 [3] 7,991 [3]
Goodwill impairment charge   22,700             22,700 [3]    
Radiation Measurement [Member]
                     
Segment Reporting Information [Line Items]                      
Revenues                 109,836 107,922 99,868
Operating income (loss)                 39,319 [2] 43,775 48,208
Depreciation and amortization                 11,180 8,377 7,032
Medical Physics [Member]
                     
Segment Reporting Information [Line Items]                      
Revenues                 30,859 30,937 20,590
Operating income (loss)                 3,507 [2] 1,334 (490)
Depreciation and amortization                 1,185 1,419 959
Medical Products [Member]
                     
Segment Reporting Information [Line Items]                      
Revenues                 9,505 13,541  
Operating income (loss)                 (21,828) [2] 5,297  
Depreciation and amortization                 2,559 1,835  
Corporate [Member]
                     
Segment Reporting Information [Line Items]                      
Operating income (loss)                 $ (16,878) [2] $ (22,236) $ (12,835)
[1] Third quarter of fiscal 2013 includes a $22,700 impairment charge. The fourth quarter of fiscal 2013 includes correction of certain errors relating to prior periods.  The corrections decreased operating income by approximately $350 and increased equity in income of joint ventures by approximately $300. The Company does not believe these corrections were material to any current or prior interim or annual periods that were affected.
[2] Fiscal 2013 includes $22,700 impairment charge.
[3] Restated